The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1

Substantia nigra in Parkinson’s disease: a multimodal MRI comparison between early and advanced stages of the disease

(2013) Domenico Aquino et al.   NEUROLOGICAL SCIENCES

Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study

(2012) Andreas R Kupsch et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0

(2011) D. S. W. Djang et al.   JOURNAL OF NUCLEAR MEDICINE

Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease

(2009) M. M Ponsen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3-year European multicenter study with repeat [123I]FP-CIT SPECT

(2009) Vicky L. Marshall et al.   MOVEMENT DISORDERS

Transcranial sonography in movement disorders

(2008) Daniela Berg et al.   LANCET NEUROLOGY

The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study

(2008) Alexandra Gaenslen et al.   LANCET NEUROLOGY

Brain magnetic resonance imaging (MRI) in parkinsonian disorders

(2008) Oraporn Sitburana et al.   PARKINSONISM & RELATED DISORDERS